MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.hpb.2020.11.1147

Медицинская библиотека · HPB : the official journal of the International Hepato Pancreato Biliary Association · 2020

Biliary intervention rates during neoadjuvant therapy for adenocarcinoma of the pancreatic head.

Kirkpatrick Stacey, Gillies Gwendolyn, Underwood Patrick, Cioffi Jessica, Trevino Jose G, Hughes Steven J

СтатьяПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

BACKGROUND

Neoadjuvant therapy prior to resection of adenocarcinoma of the pancreatic head increases time to surgery and thus the possibility of biliary complications. We hypothesized that biliary complications during neoadjuvant therapy negatively impact clinical outcomes.

METHODS

We completed a retrospective study of a cohort of borderline resectable patients consistently treated with neoadjuvant therapy from May 2014 through March 2019. Biliary complications were defined as new-onset biliary obstruction, existing stent failure, cholecystitis, and cholangitis.

RESULTS

Of 59 patients that met inclusion criteria, 34 (57.6%) went on to resection. Biliary complications affected 16 patients (27%); 8 (50%) of these patients went on to surgical resection. Of those 43 patients who did not have a biliary intervention, 26 went on to surgical resection (60.4%). There was no significant effect of a biliary complication on total number of chemotherapy cycles (p = 0.12), proceeding to surgical resection (p = 0.56) or on median survival (p = 0.23). Among patients who did proceed to surgery, there was a notable difference in median survival for patients who required a biliary intervention (17.9 vs 31.0 months) that did not reach significance (p = 0.35).

CONCLUSION

The need for further biliary interventions during neoadjuvant therapy for pancreatic adenocarcinoma is common, but does not appear to have a significant effect on number of cycles of neoadjuvant therapy or proceeding to surgical resection. Larger studies are necessary to determine if these events compromise overall survival.

Для цитирования: Kirkpatrick Stacey, Gillies Gwendolyn, Underwood Patrick, Cioffi Jessica, Trevino Jose G, Hughes Steven J. Biliary intervention rates during neoadjuvant therapy for adenocarcinoma of the pancreatic head.. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2020. DOI: 10.1016/j.hpb.2020.11.1147.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.